EBOT common mistakes
EBOT · Understand the traps and how to avoid them.
When asked which patients need urgent intervention for febrile neutropenia, the candidate waits for culture results or for the fever to persist before recommending empiric broad-spectrum antibiotics, or omits antipseudomonal coverage in a stable-appearing patient.
Candidates trained on general medicine algorithms default to 'culture first, then treat,' and they underestimate how rapidly neutropenic sepsis deteriorates; the stable appearance of the patient at presentation reinforces watchful waiting.
What to do instead
Memorize the rule that febrile neutropenia is a medical emergency: draw blood cultures and other cultures, then start empiric antipseudomonal beta-lactam therapy within roughly one hour, without waiting for results. On practice items, always identify the time-critical step and select the answer that initiates empiric coverage rather than the one that confirms the diagnosis first.
The candidate treats a rising tumor marker or a new small lesion on imaging as proof of progression and selects immediate discontinuation of an effective, well-tolerated targeted therapy, ignoring pseudoprogression or flare phenomena.
Response criteria in immunotherapy and some targeted agents differ from classic RECIST intuition; candidates conflate 'new lesion equals failure' with all settings and forget confirmatory imaging requirements.
What to do instead
Before answering, ask which therapy class is involved. For immunotherapy, recall that response criteria allow for pseudoprogression and often require confirmation of progression on repeat imaging; for hormonal or targeted agents, recall flare and pseudoprogression patterns. Choose the option that confirms progression or continues therapy with reassessment when the clinical picture is discordant.
When a patient with metastatic disease presents with new back pain and leg weakness, the candidate orders imaging first and delays corticosteroids, or selects radiotherapy alone without addressing cord compression urgently.
The candidate anchors on the pain complaint and works through a standard diagnostic workup, forgetting that neurologic deficit from cord compression is a time-dependent emergency where steroids precede definitive imaging and treatment.
What to do instead
Build a reflex: new back pain plus any neurologic sign in a cancer patient means suspected spinal cord compression. Select immediate high-dose dexamethasone, urgent MRI of the whole spine, and prompt definitive therapy (surgery or radiation) as the correct sequence. Practice recalling that steroids are started before imaging is complete.
The candidate interprets a hazard ratio or p-value in an abstract as directly describing an individual patient's absolute benefit, or concludes that a statistically significant overall survival difference in a subgroup analysis establishes that subgroup benefit.
Statistical literacy gaps: candidates conflate relative and absolute measures, ignore confidence intervals and number needed to treat, and treat unplanned subgroup analyses as confirmatory evidence.
What to do instead
For every statistics item, extract the absolute effect (event rates in each arm, absolute risk reduction, NNT) alongside the relative measure, check whether the confidence interval crosses the null, and classify subgroup findings as hypothesis-generating unless pre-specified and interaction-tested. Practice converting a hazard ratio with known baseline risk into approximate absolute benefit.
The candidate selects a chemotherapy regimen or dose without adjusting for organ function, performance status, or intent of therapy, or continues full-dose myelosuppressive therapy in a patient with poor performance status because the regimen is 'standard.'
Memorizing regimens as fixed protocols rather than as tools matched to patient and intent; candidates underweight the difference between curative and palliative intent when weighing toxicity.
What to do instead
Before selecting a regimen, explicitly state the intent (curative versus palliative), the performance status, and relevant organ function. Then apply dose modification or choose a less intensive regimen when performance status or organ function is poor. On exam items, eliminate options that ignore intent or organ function even if the drug names look familiar.
The candidate answers communication and ethics items by choosing the option that withholds a poor prognosis to 'maintain hope,' or that lets family members decide whether the patient is told the diagnosis.
Cultural and personal assumptions about protecting patients from bad news, plus confusion between beneficence and paternalism, lead candidates away from the autonomy-centered standard.
What to do instead
Apply the default that competent adults are entitled to truthful information about diagnosis, prognosis, and options, and that hope can be maintained alongside honesty. Choose options that assess the patient's information preferences, disclose at the patient's pace, and confirm decision-making capacity before involving surrogates.
The candidate manages a malignant bowel obstruction or severe cancer pain by recommending nothing by mouth and opioids only after imaging is complete, or under-treats pain because of unfounded fear of respiratory depression or addiction.
Acute-care habits and opioid misconceptions dominate over palliative principles; candidates also forget that symptom control in advanced disease is itself appropriate treatment.
What to do instead
Recall that malignant bowel obstruction management includes antisecretory agents, antiemetics, and corticosteroids, with decompression and surgery considered by prognosis, not by a blanket nil-per-os rule. For cancer pain, titrate opioids to effect with appropriate monitoring, and treat addiction concerns as irrelevant to the acute management of severe pain in a patient with cancer.
The candidate recommends adjuvant chemotherapy or radiation for a patient based on stage alone, without checking whether the patient has already received that treatment, what the margin and nodal status are, or whether the patient is fit enough to benefit.
Stage-based pattern matching replaces the multidisciplinary synthesis of pathology, prior treatment, and patient fitness that adjuvant decisions require.
What to do instead
For any adjuvant or multidisciplinary item, list the inputs before choosing: pathologic stage and margins, nodal status, prior therapies received, performance status, and patient preferences. Then select the option consistent with a multidisciplinary recommendation rather than the single modality that matches the stage.
The candidate attributes new pulmonary infiltrates, diarrhea, or rash in a patient on immunotherapy to infection or to the underlying cancer and continues the immune checkpoint inhibitor, missing an immune-related adverse event.
Immune-related adverse events mimic common conditions and can occur weeks to months after starting therapy; candidates under-recognize the temporal pattern and the possibility of delayed onset.
What to do instead
For any new symptom in a patient on checkpoint inhibitors, run through the immune-related adverse event differential (colitis, pneumonitis, hepatitis, endocrinopathy, dermatitis). Select the option that holds the drug, grades the toxicity, and starts corticosteroids for significant events, rather than the option that treats empirically for infection and continues therapy.
The candidate answers a radiation oncology item by choosing a dose or fractionation schedule without considering tumor type, intent, normal-tissue tolerance, or whether the question is about palliation versus definitive treatment.
Radiation questions reward conceptual understanding of radiobiology and tolerance rather than memorized numbers, and candidates substitute a remembered dose for clinical reasoning about intent and tolerance.
What to do instead
Before selecting a dose or schedule, identify the intent (definitive, adjuvant, palliative), the tumor's radiosensitivity, and the dose-limiting normal tissue nearby. Then choose the option that matches that reasoning. When a question offers stereotactic versus conventional fractionation, decide based on lesion size, location, and tolerance rather than on familiarity.